Next-Gen Point-of-Care Compact Systems to Drive Growth in the Global Flow Cytometry Market, According to New Report by Global Industry Analysts, Inc.

GIA announces the release of a comprehensive global report on Flow Cytometry markets. The global market for Flow Cytometry is projected to reach US$2.3 billion by 2018, primarily driven by the advent of technically advanced Flow Cytometers, enhanced fluorescent dyes, integration of multiplexing, imaging and other complementary technologies. Development and introduction of easy-to-use and compact laser systems would extend the application of Flow Cytometry to customized clinical laboratories and beyond in the next few years.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Flow Cytometry: A Global Strategic Business Report

San Jose, California (PRWEB) November 02, 2012

Follow us on LinkedIn – Defined as a method of examining physical and chemical characteristics of cells or other biological particles, flow cytometry combines optical and fluorescence detection techniques with specialized fluidics, electronics and computer technology. Biological particles including cell subsets, DNA, cells, bacteria and surface antigens are identified by fluorescent labeling of extra or intracellular markers using marker-specific antibodies. Flow cytometry is used in clinical as well as research settings, for the analysis of both fixed and live samples of cells. In clinical settings, flow cytometry is used for prognosis and diagnosis of diseases such as HIV and cancer, assessing organ transplants as well as optimization of therapy. In research settings, the technique is used in a number of applications including RNA/DNA analysis, cell viability assays, drug resistance profiling in malignancies, signal transduction assays, immunophenotyping and cell viability assays among others. The technology is also used in several other research applications such as drug discovery, stem cell sorting, marine biology and environmental sciences, and microbiology.

Presently, the global demand for small-sized, robust and high throughput flow cytometers designed for use in a number of clinical and research applications is dominant. Growth drivers expected to propel the flow cytometry market include imminent prospects in immunology, biochemistry, microbiology, cytogenetics, chemical engineering, agronomy, molecular biology, and cytology applications. Also, innovations in the areas of stem cell research, monoclonal antibodies, marine biology, computer science, electronics and fluorochrome chemistry are likely to encourage market growth.

Long-term growth in the market would stem from development of next generation, point-of-care, compact systems. In terms of sophistication, newer integrated systems are increasingly incorporating innovative features, functions, and applications. Newer instruments from leading players designed to meet the high productivity requirements of researchers feature sorting rates of up to 70,000 events/second. Several modern cytometers are equipped with varying fluorescence detectors and lasers, which enable labeling of multiple antibodies. A few recently launched instruments are also capable of taking digital images of individual cells. Despite the rapid growth forecast, lack of awareness is the main drawback for flow cytometers. Though a number of technologically advanced flow cytometers are available in the market, several end-users are still not aware of the upgraded versions.

As stated by the new market research report on Flow Cytometry, the US represents the largest regional market for Flow Cytometers accounting for a majority share in the revenues generated in the global market. Asia-Pacific represents the fastest growing regional market with annual revenue from the region exhibiting a CAGR of about 11.6% over the analysis period. Despite being a relatively small market, demand for advanced medical and analytical equipment is witnessing steady growth in countries such as India, driven by advances in biotechnology and pharmaceuticals sectors. The trend is exemplified by rise in imports of specific R&D equipment such as biotech and pharmaceutical R&D equipment, pharmaceuticals reference studies as well as certain life saving drugs and medical products.

The global flow cytometry market is highly concentrated with only two major companies dominating the market - Becton, Dickinson and Company, followed by Danaher/Beckman Coulter. Other leading players profiled in the study include Advanced Analytical Technologies, Inc., Amnis Corporation, Bangs Laboratories, Inc., Cytek Development, Inc., eBioscience, Inc., Life Technologies Corporation, Luminex Corp., Merck Millipore, and PointCare Technologies, Inc., among others.

The research report titled “Flow Cytometry: A Global Strategic Business Report” announced by Global Industry Analysts, Inc., provides a comprehensive review of market trends, issues, drivers, company profiles, mergers, acquisitions and other strategic industry activities. The report provides market estimates and projections for Flow Cytometers (in US$) for major geographic markets including the US, Canada, Japan, Europe (France, Germany, Italy, UK and Rest of Europe), Asia-Pacific and Latin America.

For more details about this comprehensive market research report, please visit –
http://www.strategyr.com/Flow_Cytometry_Market_Report.asp

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Follow us on LinkedIn

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/

###


Contact

Attachments